PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 27679543-0 2016 Electrochemotherapy with bleomycin is effective in BRAF mutated melanoma cells and interacts with BRAF inhibitors. Bleomycin 25-34 B-Raf proto-oncogene, serine/threonine kinase Homo sapiens 51-55 27679543-0 2016 Electrochemotherapy with bleomycin is effective in BRAF mutated melanoma cells and interacts with BRAF inhibitors. Bleomycin 25-34 B-Raf proto-oncogene, serine/threonine kinase Homo sapiens 98-102 27679543-7 2016 Furthermore, the synergistic interaction between vemurafenib and ECT with bleomycin was demonstrated in the BRAF V600E mutated melanoma cells. Bleomycin 74-83 B-Raf proto-oncogene, serine/threonine kinase Homo sapiens 108-112 23856246-5 2013 Furthermore, we identify pharmacogenomic correlations between specific variants in genes such as TP53, BRAF, ERBBs, and ATAD5 and anticancer agents such as nutlin, vemurafenib, erlotinib, and bleomycin showing one of many ways the data could be used to validate and generate novel hypotheses for further investigation. Bleomycin 192-201 B-Raf proto-oncogene, serine/threonine kinase Homo sapiens 103-107